Healthcare Sector Analytics

Market size, company revenue, drug approvals, clinical trials, regulation, hospitals, doctors, drug spending, labs and devices

Brand drugAntibiotic

Vibramycin(Doxycycline Hyclate)Pfizer Inc. logoPFE

Medicare prescription drug cost, prescriptions and prescribers, 2024 · made by Pfizer Inc.

$400

Medicare cost, 2024

Medicare drug plans spent $400 on Vibramycin (doxycycline hyclate) in 2024, for 20 prescriptions and refills filled by 13 patients. Spending fell 48% from 2023 to 2024. It is made by Pfizer Inc. (PFE).

Medicare cost, 2024

$400

-48.2% from 2023

Prescriptions

20

$19.98 per claim

Patients

13

16 prescribers

Total spending, 2024

$400

$30.74 per patient

Questions and answers

How much does Medicare spend on Vibramycin?

Medicare prescription drug plans paid $400 for Vibramycin in 2024, for 20 prescriptions and refills to 13 patients (down 48.2% from 2023). The average cost per claim was $19.98.

Who makes Vibramycin?

Vibramycin is made by Pfizer Inc. (PFE), listed in the Medicare spending data as Pfizer US Pharm.

Spending over the years

Medicare spending by year

All plans and makers

Prescriber data: cost by year

Medicare spending on Vibramycin was $400 in 2024, after a high of $1,479 in 2020.

By state

Where the prescribers practice, 2024

Medicare cost by state

States with the highest cost

Prescriber data by year

YearPrescribersClaimsPatientsCost
2023253223$771
2024162013$400

Makers, 2024

Spending by manufacturer as listed in the spending data

ManufacturerClaimsSpending
Pfizer US PharmPFE logoPFE20$400

More drugs: Medicare drug spending and the Prescriptions view.

Official US government data on Medicare prescription drug plans (Part D) and Medicaid drug use. Cost and spending are before the rebates drug makers pay. Prescribers with fewer than 11 claims of the drug are not published.

LinkedInLinkedInXXYouTubeYouTube